CVS Health Corporation $CVS Shares Sold by City State Bank

City State Bank decreased its position in CVS Health Corporation (NYSE:CVS) by 9.6% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,302 shares of the pharmacy operator’s stock after selling 245 shares during the period. City State Bank’s holdings in CVS Health were worth $159,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Avion Wealth boosted its holdings in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares during the period. Harbor Asset Planning Inc. purchased a new stake in shares of CVS Health in the 2nd quarter valued at about $30,000. Bell Investment Advisors Inc raised its holdings in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the last quarter. Roxbury Financial LLC raised its position in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 202 shares during the last quarter. Finally, ORG Partners LLC raised its position in CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Price Performance

NYSE:CVS opened at $81.95 on Friday. CVS Health Corporation has a one year low of $43.56 and a one year high of $83.52. The company has a market cap of $103.94 billion, a P/E ratio of 22.89, a P/E/G ratio of 0.89 and a beta of 0.60. The firm’s fifty day moving average price is $75.57 and its two-hundred day moving average price is $68.67. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to analysts’ expectations of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period last year, the firm posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. CVS Health’s dividend payout ratio is 74.30%.

Insider Activity

In related news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.22% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of analyst reports. Leerink Partners boosted their price objective on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, October 16th. Barclays lifted their target price on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Cantor Fitzgerald restated an “overweight” rating and issued a $78.00 price target on shares of CVS Health in a research note on Tuesday, August 26th. Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Sunday, September 21st. Finally, The Goldman Sachs Group started coverage on CVS Health in a research note on Tuesday, October 14th. They issued a “buy” rating and a $91.00 price objective for the company. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $83.38.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.